Kyotsujigyo
  Contact us
YHK
DTS
MMT
home   |   what's new  |   company profile   |   research   |   partners   |   sitemap

What's New | Past News

Chapter 2-2Taking YHK can reduce the costs of improving liver function greatly.


hepatitis C   fatty liver   liver disease   liver cirrhosis   NASH liver
Taking YHK can reduce the costs of improving liver function greatly.
Taking YHK from the beginning to the normalization of liver function, the average expenses are not more than 900 dollars. 90% of the patients can regain normal liver function by spending only 300 dollars.
According to the standard treatment of hepatitis C, to compare the therapy costs of six months with that of taking YHK, the result is obvious.
Fees of standard treatments are 15,000 dollars to 30,000 dollars for six months in Japan. Besides these, about 5,000 dollars would be needed for a variety of hospitalization expenses like examination expenses, commission charges and so on. Although the medical insurance can pay you the most curing expenses, unable to work because of hospitalization and income decreases caused by this problem can not be solved. And various side effects can not be avoided too.
Taking YHK for six months, the first month is on six daily uses and the remaining five months of three daily uses. The cost is about3,500 dollars.
Patients have no use for hospitalization, so one can not worry about the income decreases caused by absence from duty.
So, the advantages of YHK are obvious for it can improve liver function effectively in a short time and reduce the financial burden of patients significantly.

Author : XIE XINFAN    2008-03-22

Garlic compound a potential diabetes drug
Eggs 'increase risk of diabetes'
Broccoli and cabbages may offer protection to cancer patients
Liver transplant patients should know possible risks
Psychotherapy help with type 1 diabetes control
Kidney Cancer Risk Could Be Increased By Genes Associated With Fat Metabolism
Awareness on hepatitis, fatty liver, liver cirrhosis, and liver cancer
Nurses at risk of hepatitis C for injury by needle
CDC defines higher-risk category of hepatitis B
Cancer drugs halt type 1 diabetes in mice
Woman who contracted HIV and hepatitis C from a kidney transplant sues hospital
Caution on Liver, thyroid cancer in Canada


home   |   what's new  |   company profile   |   research   |   partners   |   Contact us  |   sitemap
kenkyusho ltd 1999 - 2007©